EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)
Conditions
Non Small Cell Lung Cancer
Conditions: official terms
Carcinoma, Non-Small-Cell Lung
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case Control, Time Perspective: Prospective
Intervention
Name: EBUS_TBNA
Type: Procedure
Overall Status
Recruiting
Summary
The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).
Detailed Description
NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 80 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Age ≥ 18 years

- Samples are collected before surgery or before any therapy

- ECOG 0 or 1

- Clinical stage I-II, T1-2, N0-1, M0)

- Surgically respectable

- Patient with enlarged med. lymphnodes (control group)

Exclusion Criteria:

- Previous RT/CHT

- Previous or current cancer of other entity
Location
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care
Heidelberg, Germany
Status: Recruiting
Contact: Michael Kreuter, MD - 49 / 6221 / 396 - michael.kreuter@thoraxklinik-heidelberg.de
Start Date
October 2009
Completion Date
January 2011
Sponsors
Heidelberg University
Source
Heidelberg University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page